Patient Care Pharmaceutical Companies Vaccines 
Pharmacy Times
JUNE 24, 2025
This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen Pharmaceutical Companies), and lenalidomide. 2 We’re still trying to figure out where these new treatments best fit.
Viseven
MARCH 25, 2025
In healthcare, business intelligence plays an especially important role, as it can be used to create better treatments, personalize patient care, prevent diseases, keep patients’ personal info safe, and even detect fraud. It’s as simple as it gets: the better your data analysis is, the better the care you provide.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Viseven
JANUARY 15, 2025
Artificial intelligence can assist governments and healthcare institutions in combating pandemics , including monitoring and predicting outbreaks, speeding up diagnostics and research, repurposing existing drugs, and even accelerating vaccine design and development. AI in life sciences is a lot more than just a tool for optimization.
European Pharmaceutical Review
OCTOBER 24, 2022
The number of industry clinical trials initiated in the UK, per year, fell by 41 percent from 2017 to 2021, according to the latest annual report on clinical research from the Association of the British Pharmaceutical Industry ( ABPI ).
European Pharmaceutical Review
JUNE 16, 2023
With the adoption of digital technologies gaining traction in many industries, pharmaceutical companies must take advantage of digitalisation within its research and development (R&D) sector. This approach facilitates a comprehensive understanding of medical information and enhances the management of patient care.
pharmaphorum
JULY 1, 2021
More recently, the rapid development of Moderna’s COVID-19 vaccine, which used many of the principles of synthetic biology, is yet more proof that this is an area on the cusp of the pharmaceutical R&D mainstream. Funding radical innovation. About the interviewee.
pharmaphorum
DECEMBER 21, 2021
In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). Yet a successful COVID-19 vaccine gained emergency approval in just 11 months, a blistering pace that likely saved millions of lives.
Expert insights. Personalized for you.
123 
Let's personalize your content